Collectively, these data show that cancer significantly disrupts the circadian expression of REGs in skeletal muscle, including a loss of rhythmicity in clock-controlled genes related to metabolic function and a gain in rhythmicity in genes associated with the muscle atrophy phenotype—many of which were dependent on FoxP1. This evidence concerns the gene CLOCK and cancer.